TCR激活对CD8而非CD4 CAR T细胞扩增与白血病清除的负面影响
该研究利用免疫健全的同基因小鼠模型,将具有已知TCR特异性的CD19 CAR T细胞用于前B细胞急性淋巴细胞白血病治疗。结果显示,当TCR抗原存在时,CD8 CAR T细胞的疗效丧失,并伴随T细胞耗竭和凋亡;而CD4 CAR T细胞在TCR刺激下仍保持体内疗效,且其细胞毒性与CD8 CAR T细胞相当。基因表达谱提示双受体刺激下CD8 CAR T细胞耗竭与凋亡增加,CD4与CD8 CAR T细胞在T细胞相关信号通路使用上存在内在差异。
要点
- TCR抗原存在时CD8 CAR T细胞疗效丧失,伴耗竭与凋亡。
- CD4 CAR T细胞细胞毒性与CD8相当,TCR刺激下仍保持体内疗效。
- 双受体刺激下CD8较CD4 CAR T细胞耗竭与凋亡基因表达增加。
核心结论
- TCR激活负向影响CD8而非CD4 CAR T细胞的扩增与白血病清除,CD4与CD8 CAR T细胞在信号通路使用上存在内在差异。
研究设计与样本
- 免疫健全同基因小鼠模型,CD19 CAR导入具有已知TCR特异性的T细胞,用于前B细胞急性淋巴细胞白血病治疗。
主要发现
- TCR抗原存在时CD8 CAR T细胞疗效丧失,与T细胞耗竭和凋亡相关。
- CD4 CAR T细胞细胞毒性与CD8 CAR T细胞相当,且在TCR刺激下仍保持体内疗效。
- 基因表达谱显示双受体刺激下CD8较CD4 CAR T细胞耗竭与凋亡增加,并提示两者在T细胞相关信号通路使用上存在内在差异。
临床怎么用
- 结果为CAR T细胞免疫生物学提供认识,并提示可理性设计CAR构建体以优化临床疗效。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chimeric antigen receptor (CAR)-expressing T cells induce durable remissions in patients with relapsed/refractory B cell malignancies. CARs are synthetic constructs that, when introduced into mature T cells, confer a second, non-major histocompatibility complex-restricted specificity in addition to the endogenous T cell receptor (TCR). The implications of TCR activation on CAR T cell efficacy has not been well defined. Using an immunocompetent, syngeneic murine model of CD19-targeted CAR T cell therapy for pre-B cell acute lymphoblastic leukemia in which the CAR is introduced into T cells with known TCR specificity, we demonstrate loss of CD8 CAR T cell efficacy associated with T cell exhaustion and apoptosis when TCR antigen is present. CD4 CAR T cells demonstrate equivalent cytotoxicity to CD8 CAR T cells and, in contrast, retain in vivo efficacy despite TCR stimulation. Gene expression profiles confirm increased exhaustion and apoptosis of CD8 CAR T cells upon dual receptor stimulation compared to CD4 CAR T cells and indicate inherent differences between CD4 and CD8 CAR T cells in the use of T cell-associated signaling pathways. These results provide insights into important aspects of CAR T cell immune biology and indicate opportunities to rationally design CAR constructs to optimize clinical efficacy.
引用
- Yang Y, Kohler ME, Chien CD, et al. TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance. Sci Transl Med. 2017. PMID: 29167392. doi:10.1126/scitranslmed.aag1209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。